This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
How does Reishi mushroom spore powder work in the body?
Reishi spores contain concentrated ganoderic acids and triterpenoids that modulate immune function through beta-glucan receptor activation on immune cells. These compounds influence cytokine production and enhance natural killer cell activity. The triterpenoids also demonstrate anti-inflammatory properties by inhibiting inflammatory mediators. Evidence Level C supports these proposed mechanisms based on laboratory and preliminary human studies. Cracked spores provide higher bioavailability than whole mushroom preparations due to improved release of active compounds from the hard spore shell.
Can I take Reishi spores with blood thinners or other medications?
Reishi spores may interact with anticoagulant and antiplatelet medications, potentially increasing bleeding risk due to compounds that affect platelet aggregation. Those taking warfarin, aspirin, or similar blood thinners should avoid Reishi supplements. Additionally, Reishi may interfere with immunosuppressant medications and certain chemotherapy agents by stimulating immune activity. Evidence Level C indicates these theoretical interactions require caution. Always consult a healthcare provider before combining Reishi with prescription medications, especially before scheduled surgery.
What is the recommended dosage for Reishi spore powder?
The standard adult dosage for cracked Reishi spore powder is 1-2 grams daily, typically divided into two doses. Cracked spores are essential, as the hard spore shell prevents absorption of active compounds. Higher doses do not necessarily improve results and may increase side effect risk. Traditional Chinese Medicine practitioners may adjust dosages based on individual constitution. Evidence Level C supports this range based on traditional use and preliminary research, though optimal dosing requires further clinical study.
Is Reishi mushroom safe during pregnancy and breastfeeding?
Reishi spore supplements are considered unsafe during pregnancy and breastfeeding due to insufficient safety data and potential effects on immune modulation. Some compounds may stimulate uterine contractions or affect fetal development. Breastfeeding mothers should also avoid Reishi as active compounds may transfer through breast milk. Women who are pregnant, trying to conceive, or nursing should consult a qualified healthcare provider before using any medicinal mushroom supplements.
What are the side effects of taking Reishi mushroom spores?
Common side effects of Reishi spore powder include dry mouth, mild gastrointestinal upset, dizziness, and occasionally nosebleeds. These effects typically occur with higher doses or in sensitive individuals. Long-term use may rarely cause liver enzyme elevations in susceptible people. Side effects usually resolve when discontinuing supplementation. Those with mushroom allergies should exercise caution. Evidence Level C indicates these adverse effects are documented in case reports and traditional use records. Discontinue use if persistent symptoms develop.
What are the health benefits of Reishi mushroom spores?
Reishi spores are traditionally used as a longevity tonic and adaptogen for stress resilience. Preliminary research suggests potential benefits for immune modulation, anti-tumor activity, and cardiovascular health. The concentrated ganoderic acids in spores may offer stronger effects than standard Reishi extracts. Traditional Chinese Medicine considers Reishi an imperial herb for promoting vitality and calm. Evidence Level C indicates promising preliminary findings, though robust human clinical trials are needed to confirm specific health benefits.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Ganoderma lucidum spores (GLS) are mature germ cells containing genetic substances and active components that exhibit immunomodulatory, antitumor, and antioxidant effects [PMID:31677143, PMID:39701732].
Background
Ganoderma lucidum spores are the mature germ cells of the Ganoderma lucidum fungus [PMID:31677143]. They possess a hard, indissolvable sporoderm (spore wall) that can limit the bioavailability of bioactive components, leading to the development of sporoderm-broken (BGLS) and sporoderm-removed (RGLS) preparations to enhance absorption and efficacy [PMID:28385047, PMID:41584839, PMID:38038157].
Traditional uses
Ganoderma lucidum is traditionally used to prevent and treat liver disorders, hypertension, insomnia, diabetes, and cancer [PMID:37790044], and is used in Chinese traditional formulas as a nootropic to improve cognitive dysfunction in Alzheimer's disease [PMID:33352241].
Active compounds
Main active constituents include triterpenoids (such as ganoderic acids A, B, C2, C6, G, H and ganoderenic acids B, C) [PMID:22361494, PMID:39701732], polysaccharides [PMID:40846013, PMID:42278270], and lipids/sterols including oleic acid, linoleic acid, ganoderin A, chaxine B, ergosterol, and stellasterol [PMID:36481405, PMID:28414246].
Mechanism of action
Mechanisms include regulating Th17/Treg homeostasis and restoring gut microbiota balance in colitis [PMID:40846013], activating autophagy via the Keap1/Nrf2 pathway to reduce lipid accumulation and oxidative stress in the liver [PMID:39765829], and inducing apoptosis in leukemia cells via MAPK and PI3K pathways [PMID:22172327]. In osteosarcoma, RGLS targets glycerophospholipid and fatty acid metabolism by upregulating lysophosphatidylcholine (LysoPC) through PLA2-mediated pathways [PMID:40596188].
Sporoderm-broken spore powder (SSPL) lowered weight gain, improved serum/liver lipid levels, and decreased expression of TNF-α, IL-6, and IL-1β [PMID:36340916]
Evidence DRheumatoid Arthritis (Mice)
GLS oil reduced clinical scores for RA, cartilage degeneration, and synovial membrane inflammation [PMID:36481405]
A 26-week repeated dose toxicity evaluation in rats (0 to 4.0 g/kg daily) of sporoderm-removed GLS (RGLS) showed no significant systemic toxicity [PMID:37944784].
Pregnancy & lactation
Developmental and reproductive toxicity (DART) assessments including embryo-fetal developmental toxicity in rats and whole-embryo culture in rabbits were conducted to support clinical application in maternal and perinatal populations [PMID:41584839].
Evidence summary
The majority of evidence is derived from animal models (mice/rats) and in vitro studies (Level D), demonstrating broad anti-inflammatory, antitumor, and metabolic benefits. There is one clinical trial protocol (Level B) currently addressing fatigue in lung cancer patients.
PubMed sources
1.PMID: 31677143 (2019) — Researches and Application of Ganoderma Spores Powder. · Advances in experimental medicine and biology
2.PMID: 37790044 (2023) — Pharmacological Activities and Safety of Ganoderma lucidum Spores: A Systematic Review. · Cureus
3.PMID: 40846013 (2025) — Sporoderm-broken of Ganoderma lucidum spore polysaccharides alleviate dextran sulfate sodium-induced colon inflammation in mice by regulating Th17/Treg homeostasis and restore gut microbiota balance. · International journal of biological macromolecules
4.PMID: 40809511 (2025) — Spore-inspired inhalation drug delivery system for asthma therapy. · Bioactive materials
5.PMID: 36340916 (2022) — Sporoderm-broken spore powder of Ganoderma lucidum ameliorate obesity and inflammation process in high-fat diet-induced obese mice.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
GLSP reduced lipid accumulation and oxidative stress by activating autophagy [PMID:39765829]
Evidence DThymic Atrophy (Mice)
GLS mitigated EB-induced thymic damage and enhanced CD4+ T cell output [PMID:39221140]
Evidence BFatigue in NSCLC (Human)
Protocol for a randomized, double-blind, placebo-controlled study to investigate if GLSP improves fatigue in patients using Osimertinib [PMID:38500118]
7.PMID: 22361494 (2011) — Triterpenoids from the spores of Ganoderma lucidum. · North American journal of medical sciences
8.PMID: 37944784 (2023) — A 26-week repeated dose toxicity evaluation of sporoderm-removed Ganoderma lucidum spores in rats. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
9.PMID: 40596188 (2025) — Multi-omics analysis reveals inhibition of osteosarcoma progression by sporoderm-removed Ganoderma lucidum spores via targeting glycerophospholipid and fatty acid metabolism. · Scientific reports
10.PMID: 36481405 (2023) — Inhibitory effects of Ganoderma lucidum spore oil on rheumatoid arthritis in a collagen-induced arthritis mouse model. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
11.PMID: 42278270 (2026) — Sporoderm Disruption Reshapes the Chemical Characteristics and Enhances the Mitochondrial Protective Activity of Ganoderma lucidum Spore Polysaccharides via SIRT1/AMPK Signaling. · International journal of molecular sciences
12.PMID: 37262935 (2023) — Modifications of Ganoderma lucidum spores into digestive-tissue highly adherent porous carriers with selective affinity to hydrophilic or hydrophobic drugs. · Biomaterials
13.PMID: 39701732 (2024) — [UPLC-Q-TOF-MS/MS qualitative analysis and HPLC determination of triterpenoids in Ganoderma lucidum spores]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
14.PMID: 38720779 (2024) — Sporoderm-removed Ganoderma lucidum spores ameliorated early depression-like behavior in a rat model of sporadic Alzheimer's disease. · Frontiers in pharmacology
15.PMID: 39765829 (2024) — Ganoderma lucidum Spore Powder Alleviates Metabolic-Associated Fatty Liver Disease by Improving Lipid Accumulation and Oxidative Stress via Autophagy. · Antioxidants (Basel, Switzerland)
16.PMID: 26952490 (2016) — Preparation and characterization of Ganoderma lucidum spores-loaded alginate microspheres by electrospraying. · Materials science & engineering. C, Materials for biological applications
17.PMID: 39221140 (2024) — Protective effects of Ganoderma lucidum spores on estradiol benzoate-induced TEC apoptosis and compromised double-positive thymocyte development. · Frontiers in pharmacology
18.PMID: 38500118 (2024) — Synergy of de-walled Ganoderma Lucidum spore powder (GLSP) on targeted therapy in advanced non-squamous non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutant: protocol for a randomized, double-blind, placebo-controlled study. · BMC complementary medicine and therapies
19.PMID: 41508082 (2025) — [Efficacy of Ganoderma lucidum spores in invigorating spleen via spleen meridian]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
20.PMID: 22885115 (2012) — Distinction of broken cellular wall Ganoderma lucidum spores and G. lucidum spores using FTIR microspectroscopy. · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
21.PMID: 41584839 (2025) — Developmental and reproductive toxicity assessment of sporoderm-removed Ganoderma lucidum spores. · Frontiers in cell and developmental biology
22.PMID: 22381804 (2012) — A study of Ganoderma lucidum spores by FTIR microspectroscopy. · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
23.PMID: 33352241 (2021) — Prophylactic effects of sporoderm-removed Ganoderma lucidum spores in a rat model of streptozotocin-induced sporadic Alzheimer's disease. · Journal of ethnopharmacology
24.PMID: 28385047 (2017) — Breaking the sporoderm of Ganoderma lucidum spores by combining chemical reaction with physical actuation. · Natural product research
25.PMID: 18186577 (2007) — Application of proteomics in Chinese medicine research. · The American journal of Chinese medicine
26.PMID: 40461239 (2025) — [Research progress on chemical constituents and pharmacological effects of Ganoderma lucidum spore oil]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
27.PMID: 32256359 (2020) — Screening Immunoactive Compounds of Ganoderma lucidum Spores by Mass Spectrometry Molecular Networking Combined With in vivo Zebrafish Assays. · Frontiers in pharmacology
28.PMID: 22172327 (2012) — Active lipids of Ganoderma lucidum spores-induced apoptosis in human leukemia THP-1 cells via MAPK and PI3K pathways. · Journal of ethnopharmacology
29.PMID: 28414246 (2017) — Ganoderin A, a novel 9,11-secosterol from Ganoderma lucidum spores oil. · Journal of Asian natural products research
30.PMID: 38038157 (2024) — Comparative pharmacokinetic analysis of sporoderm-broken and sporoderm-removed Ganoderma lucidum spore in rat by using a sensitive plasma UPLC-QqQ-MS method. · Biomedical chromatography : BMC